Streetbeat News

Products Services

KOS

Kosmos Energy announced the successful start-up of oil production at the Winterfell development in the Green Canyon area of the US Gulf of Mexico.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2024 | 6:58 am

CVAC

GSK

GSK and CureVac have restructured their collaboration into a new licensing agreement, with GSK taking full control of developing and manufacturing mRNA vaccines. CureVac will receive €400M upfront and up to €1.05B in milestones. The agreement allows both companies to focus on their respective mRNA development activities.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2024 | 6:57 am

CVAC

GSK

GSK and CureVac have restructured their partnership to focus on mRNA vaccine development. GSK will take full control of developing and manufacturing the candidate vaccines, while CureVac will receive significant financial compensation and retain rights to other targets.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2024 | 6:53 am

ZETA

Zeta Global has launched the Zeta Economic Index, an AI-driven tool that analyzes consumer behavior to provide a comprehensive view of U.S. economic growth. The index uses data from over 240 million American adults and integrates traditional economic indicators with high-frequency information.

Portfolio Pulse from Ananya Gairola

July 03, 2024 | 6:29 am

MSFT

NVDA

Abnormal Security, an AI-powered cybersecurity startup, is set to be valued at $5 billion in its latest funding round, led by Insight Partners. The company, founded by ex-Twitter executive Evan Reiser, has seen a significant increase in valuation from $4 billion in 2022. The AI sector continues to attract substantial investments, with companies like Microsoft and Nvidia backing various AI initiatives.

Portfolio Pulse from Benzinga Neuro

July 03, 2024 | 5:22 am

SHIBUSD

Shiba Inu's marketing lead, Lucie, has hinted at a potential increase in the burn rates of SHIB tokens through a collaboration with Shibacals, a project focused on authenticating physical collectibles using blockchain technology.

Portfolio Pulse from Aniket Verma

July 03, 2024 | 4:55 am

TSLA

Tesla Inc. (NASDAQ: TSLA) is poised for new all-time highs according to Simon Hale and Rich Ross. Hale, a Senior Portfolio Manager at Wellington Altus Private Wealth, emphasized the significance of Ross's technical analysis, which aligns with their fundamental assessments. Tesla's stock surged after exceeding second-quarter delivery estimates, and Wedbush analyst Dan Ives raised the price target to $300, citing Tesla's AI potential. Gary Black also predicted a substantial increase in Tesla's market with the launch of a $25,000 vehicle and autonomous driving technology.

Portfolio Pulse from Benzinga Neuro

July 03, 2024 | 4:16 am

AMZN

ANVS

LLY

PARA

TSLA

On Tuesday, the Dow Jones, S&P 500, and Nasdaq all closed higher. Tesla, Paramount Global, Annovis Bio, Eli Lilly, and Amazon were notable stocks. Tesla surged on strong deliveries, Paramount rose on takeover speculation, Annovis Bio soared on positive drug trial data, Eli Lilly fell due to political pressure on drug prices, and Amazon hit new highs on AI optimism.

Portfolio Pulse from Benzinga Neuro

July 03, 2024 | 3:38 am

ETHUSD

Nate Geraci, president of The ETF Institute, suggests a potential mid-July launch for spot Ethereum ETFs, which could significantly impact the cryptocurrency market. The amended S-1s are due by July 8, with potential final S-1s by July 12, indicating a possible launch in the week of July 15. This could lead to substantial capital inflows and potentially increase Ethereum's value in U.S.-based spot ETFs.

Portfolio Pulse from Aniket Verma

July 03, 2024 | 2:44 am

TSLA

Gary Black, Managing Partner at Future Fund, echoed Elon Musk's warning to short sellers of Tesla Inc. (NASDAQ:TSLA), emphasizing the company's strong position in the electric vehicle market and its future potential. Black highlighted the upcoming $25,000 vehicle and Tesla's autonomous driving technology as key growth drivers. Tesla's stock has been performing well, with a recent price target increase from Wedbush analyst Dan Ives.

Portfolio Pulse from Benzinga Neuro

July 03, 2024 | 2:18 am